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Objective. To evaluate the need for information and treatment of poststroke fatigue (PSF) in community-dwelling patients with
stroke in The Netherlands. Methods. Data were obtained from a Dutch internet-based questionnaire. The amount of information
received about PSF, self-management and other treatment options, and the perceived need for treatment were scored. PSF was
assessed with two Visual Numerical Scales of fatigue severity (VNSF), the Fatigue Severity Scale (FSS7), and by scoring the nature
(physical versus mental) and onset time of PSF. Results. Data were available of 538 stroke survivors (mean age 52 years, 45%
men, and mean time since onset 2.7 years). Severe fatigue (both VNSF items ≥7; 48%) and severe fatigue impact (FSS7> 5; 68%)
were frequent. Most participants (57%) experienced both physical and mental fatigue. Only 17% of the respondents indicated to
have had received suﬃcient information about PSF and 7% about treatment options, whereas 56% expressed a substantial need
for treatment. The need for treatment was moderately associated with fatigue severity and fatigue impact, whereas information
status was not related to any demographical, fatigue, or stroke characteristic. Conclusions. PSF is a significant symptom after stroke
requiring medical attention and treatment. The results of this survey indicate that patients do not receive adequate information on
PSF.
1. Introduction
Persisting fatigue is a common and debilitating consequence
of stroke even in patients with good recovery [1–4]. Preva-
lence rates of poststroke fatigue (PSF) are substantial, varying
between 38 and 73% [4]. These rates seem to be stable over
time, with no marked decline after the postacute stage to
even years following the injury [5–9]. As no unequivocal
associations with clinical or demographical variables, such
as stroke type, age, sex, or education, have been found,
all patients who have experienced a stroke may be at
risk to develop this symptom [4]. Furthermore, PSF has
been found to have a negative eﬀect on quality of life [2,
10], rehabilitation outcomes [11], and even mortality [12–
14]. However, PSF is often misdiagnosed [11, 15, 16] and
evidence-based clinical guidelines for dealing with PSF are
scarce [17, 18].
The pathogenesis of PSF is still poorly understood [4, 12,
19, 20] but believed to be multifactorial [4, 5, 12, 14, 20–
22]. Although direct associations with biological markers
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have been demonstrated only in a few studies [20], the
brain damage itself is suggested to be a primary cause for
the experienced fatigue [23–25]. Furthermore, associations
with psychological distress such as depressive symptoms
and anxiety have been repeatedly found [4]. The direction
of this association has not been established, but somatic
complaints seem to mediate this association [22]. Moreover,
the consistent finding of double dissociations between
these symptoms underscores the distinction between these
syndromes [3, 22, 26]. However, psychological distress may
certainly exacerbate fatigue and vice versa.
It has been accepted that PSF is a multifaceted phe-
nomenon, including the severity of fatigue and the impact of
fatigue on daily life [4]. Although no uniform definition of
PSF exists, it is generally defined as “a subjective experience
of extreme and persistent tiredness, weakness, or exhaustion
after stroke, which can present itself mentally, physically or
both and which is unrelated to previous exertion levels”
[18, 27]. Since this definition is intrinsically subjective and no
derivative assessment tools have been specifically constructed
for patients with stroke, a large variety of fatigue rating
scales have been used in research and clinical practice [20,
28]. Some of these tools assess the dimension of fatigue
severity, such as Visual Analogue Scales [29] or the Checklist
Individual Strength [30]. Others, such as the Fatigue Severity
Scale, measure the impact of fatigue in daily life [31]. The
assessment of both aspects is needed to comprehensively
assess PSF and to warrant the comparability of diﬀerent
studies.
A few qualitative studies in small focus groups have
demonstrated that patients with PSF report a great need
for information on the syndrome [15, 16]. Patients reported
that the lack of information led to confusion and distress,
which in turn elongated the time needed to adjust to the
fatigue [16]. They want to understand their experience of
fatigue and have it diagnosed or explained so that they
are less overwhelmed by it and know what to do about
it [15]. Studies on the treatment of fatigue in patients
with stroke and in patients with other neurological disease
suggest that patient education, teaching energy conservation
strategies, and graded activity training can be helpful in the
management of fatigue [18, 32, 33].
Despite the importance of education and treatment for
patients with PSF, little research has been conducted to
quantitatively identify the need for education and treatment
possibilities amongst stroke survivors [17, 18]. Furthermore,
PSF is often not accurately recognized [11, 15, 16]. The aim
of the present study was to investigate the current provision
of patient information and healthcare in The Netherlands, by
an internet-based questionnaire, and to relate these needs to
demographic, fatigue, and stroke characteristics.
2. Methods
Data were obtained from a Dutch internet-based question-
naire. External links to the website were placed on the
Dutch Wikipedia site about stroke and on the website of
The Netherlands Brain Foundation (Hersenstichting). All
participants who spontaneously completed the questionnaire
consented with its use for scientific research. No feedback
about results or financial reward was given and data were
anonymously collected.
To identify current information and need status, ques-
tions about the amount of information received with regard
to (i) PSF, (ii) self-management techniques, and (iii) treat-
ment had to be answered on a 5-point Likert Scale (ranging
from none to ample information) as well was the need for
treatment of PSF (from none to a great need). The sum of
the information scores was used (range 0–15) to indicate
information status.
A Visual Numerical Scale was used to assess the severity
of fatigue (VNSF). The VNSF consisted of questions about
perceived fatigue severity (ranging from 0: no fatigue to 10:
extreme fatigue) at present (question 1) and over the past 2
weeks (question 2). A score above 6 on both VNSF items was
regarded as severe fatigue [34]. The mean of both items was
used for statistical analysis.
The Fatigue Severity Scale-7 (FSS7) [21] is a well-
validated tool to assess fatigue impact. It contains the last 7
items of the original 9-item FSS [31], to be scored on a 7-
point Likert Scale. A mean score was calculated and a higher
score than 5 indicated severe fatigue impact (range: 1–7)
[21, 31].
Additional questions about the nature of PSF (physical
versus mental) and postonset time of fatigue had to be
answered on a 5-point Likert Scale. Furthermore, data were
collected regarding date of stroke, age, years of education,
marital status, and employment. Questions on the assess-
ment itself were posed last, with regard to the amount of help
participants received during the assessment, the time needed
to complete the questionnaire, and the perceived diﬃculty of
the questionnaire.
3. Data Analysis
Double and faulty entries were identified by comparing
demographic and stroke characteristics and subsequently
discarded. Questionnaires not independently completed,
were analyzed separately. Of all the correct entries, descrip-
tive statistics were calculated. The association of information
status, fatigue severity (VNSF), and fatigue impact (FSS7)
with demographic data, age, sex, education, post-stroke time,
onset time of fatigue, and nature of PSF was tested using
Pearson’s correlation coeﬃcient for continuous and χ2-tests
for categorical variables. All analyses were conducted using
SPSS version 18 for Windows, with Sidak correction for
multiple analyses (alpha set at .004).
4. Results
Between April 2009 and June 2011 the website drew 9,204
unique visitors. The questionnaire was completed 575 times.
Of these 538 could be included, since 33 respondents sent
in multiple questionnaires and 4 participants had not had
a stroke. Primary analyses were then performed on 479
questionnaires, since 59 entries indicated that they had been
filled in with the assistance of another person (50) or had
been completed by a proxy (9).
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Table 1: Participant characteristics and correlations with VNSF and FSS7 (N = 479).
Mean ± SD% VNSF, r(P) FSS7, r(P)
Demographic and stroke data
Age (y) 52.4 ± 10.8 −.15 (<.001) n.s.
Time since stroke (y) 2.73 ± 4.72 n.s. n.s.
Gender male 45% n.s. n.s.
Education (y) 12.9 ± 2.5 n.s. n.s.
Living with partner 74% n.s. n.s.
Currently employed 57% n.s. n.s.
Fatigue
Fatigue severity (VNSF) 6.54 ± 1.85 .39 (<.001)
Both VNSF scales ≥7 48%
Fatigue impact (FSS7) 5.52 ± 1.23 .39 (<.001)
FSS7 > 5 69%
PSF (VNSF ≥ 7 ) since: n.s. n.s.
Prestroke 18%
Stroke 53%
1–6 months after stroke 19%
>6 months after stroke 10%
Information and needs
Sum of information scores 5.87 ± 2.88 n.s. n.s.
Information received on PSF∗ n.s. n.s.
None 37%
Some 46%
Suﬃcient 17%
Information on self-management∗ n.s. n.s.
None 50%
Some 37%
Suﬃcient 13%
Information on treatment∗ n.s. n.s.
None 63%
Some 30%
Suﬃcient 7%
Need for PSF treatment∗ .34 (<.001) .31 (<.001)
Currently receives treatment 10%
No need 10%
Some 24%
Substantial 56%
∗
Categories are combined to none (none), some (a little and some), and suﬃcient (suﬃcient and ample/a great need).
Table 1 list the patients’ demographic and clinical charac-
teristics, together with their information status and need for
treatment, related to the scores on fatigue severity (VNSF)
and fatigue impact (FSS7). Except for younger age, no
associations between PSF and demographic variables were
found.
Only 17% of the participants indicated they had received
suﬃcient information about PSF and 7% felt they had
received suﬃcient information about treatment options. In
contrast, 54% of the respondents expressed a substantial
need for treatment. Patients who had no need for treatment
(11%) experienced less severe fatigue (VNSF:M = 5.0± 2.0)
and reported less fatigue impact (FSS7: M = 4.8 ± 1.5) than
those currently receiving treatment (VNSF M = 7.1 ± 1.8;
FSS7 M = 5.6± 1.4) or those expressing some to substantial
need (VNSF M = 6.7± 1.7; FSS7 = 5.5± 1.2, P < .001). The
amount of need for treatment was associated with fatigue
severity and impact, but not with any demographical or
stroke variable (all P > .004). Information status was not
related to any stroke, fatigue, or demographic characteristic
(all P > .004).
The experienced nature of PSF on a physical-to-
mental dimension diﬀered greatly between participants
χ2(4) = 55.33, P < .001, with 57% of the patients expressing
both physical and mental fatigue components (Figure 1).
No associations were found between the nature of PSF
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Figure 1: Frequency of experienced nature of fatigue (N = 479).
and VNSF, FSS7, or information status (χ2 tests, all P >
.01).
Regarding the questionnaire, 51% reported having no
diﬃculty at all completing the tool, 30% a little diﬃculty,
14% some, and 5% had substantial diﬃculties with filling in
the questionnaire. For most participants (53%) completing
the questionnaire took less than 5 minutes, 37% needed 5–
10 minutes, 8% needed 11–20 minutes, and only 2% needed
more than 21 minutes.
Questionnaires that were completed with the help of
others or by proxies diﬀered from those completed indepen-
dently on several accounts. Respondents requiring help were
older (61.3 ± 1.8 years), less likely to be employed (20%),
experienced more severe fatigue (VNSFM = 7.7± 1.6), took
longer to fill in the questionnaire (Median 6 to 10 minutes),
and reported more diﬃculty filling in the questionnaire.
5. Discussion
This internet-based study was conducted to evaluate the
need for information and treatment concerning PSF in
community-dwelling patients with stroke in The Nether-
lands. The results indicate that fatigue is still a neglected
symptom after stroke, because most of the participants
did not receive suﬃcient information about (the causes)
of fatigue (83%), about self-management techniques (87%)
or other treatment options (93%). This worrisome lack
of information shows a remarkable contrast with the fact
that 54% of participants indicated a substantial need for
treatment for PSF.
A large proportion of the participants in the present
study experienced severe fatigue as assessed with the VNSF
(48%) and reported a severe fatigue impact as assessed with
the FSS7 (69%). The moderate association between both
scales reveals that diﬀerent aspects of PSF were measured.
Interestingly, fatigue scores were neither associated with sex
or post-stroke time, nor with the onset time or nature of
PSF. Only a small negative correlation with age was found.
However, patients who did not complete the questionnaire
independently were more severely fatigued and older than
those filling in the questionnaires without assistance. These
results emphasize the persistence of fatigue complaints after
stroke, irrespective of when or by whom they are reported.
Most participants experienced fatigue both physically
and mentally, which underscores the notion that PSF
includes both components. The finding that the need for
treatment was associated with fatigue severity and fatigue
impact is understandable and emphasizes the importance
of providing appropriate information. The result that the
need for information itself was not associated with fatigue
scores indicates that even patients with relatively mild fatigue
should receive adequate information about PSF and its
treatment options. It is possible that patients in fact have
received information on PSF and treatment options, but
due to their mental fatigue were unable to remember the
information. In this case, the provision of information
should be more adequately tailored to the fatigability and the
use of written information such as leaflets could be of aid
[35].
This study may have been subject to bias. Most impor-
tantly, especially participants with a great need for informa-
tion and/or need for treatment can be expected to search
the internet for information about PSF and its treatment
options. As a result, figures about fatigue severity, fatigue
impact, and lack of information may have been confounded
by selection bias. On the other hand, 63% of the participants
had received at least some information about PSF and 37%
about treatment options. In addition, our respondents were
relatively young (52 years of age), highly educated (>12
years), and 57% still were employed, suggesting preserved
cognitive functions, which should have enabled them to
receive and ask for appropriate information. Another limi-
tation is that PSF scores may have been influenced by pre-
stroke fatigue or fatigue as a result of concurrent disease(s)
occurring after stroke. Yet, prestroke fatigue was reported in
only 18% of the participants with severe fatigue, while 71%
experienced the onset of fatigue within 6months after stroke.
6. Conclusion
PSF is an important clinical symptom after stroke, requiring
attention by medical professionals as well as treatment
and/or care. It is, however, still a neglected phenomenon in
The Netherlands.
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